MedPath
TGA Approval

VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe (376618)

376618

VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe

BioMarin Pharmaceutical Australia Pty Ltd

July 6, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/c3a2539c99df26478fed7e9eb6243d83.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/6e07581e8a597967fe4de6420c5281ae.pdf

Active Ingredients

vosoritide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VOXZOGO vosoritide 1.2 mg powder for injection vial and diluent pre-filled syringe (376618) - TGA 批准文号 | MedPath